Keto diet may improve symptoms of severe mental illness
Add topic to email alerts Receive an email when new articles are posted on Please provide your email address to receive an email when…
Why H5N1 bird flu is keeping the CDC’s top flu scientist awake- STAT
Vivien Dugan isn’t getting much sleep these days. The director of the influenza division at the Centers for Disease Control and Prevention, Dugan is leading the team of CDC scientists…
Drug targeting RNA modifications shows promise for treating neuroblastoma
Credit: Pixabay/CC0 Public Domain Neuroblastoma is a common pediatric cancer that originates in developing nerve cells outside the brain. While increasingly intensive treatments have improved the survival of patients with…
Change Eligibility Rules for More Diverse Clinical Trials?
Expanding eligibility criteria is a strategy for improving the inclusion of traditionally underrepresented populations in clinical trials, according to a study. The results were published in NEJM Evidence by Maneet…
Navigating Policy Terrain: Perspectives for Payers on Tackling Ghost Networks
It’s not uncommon for a patient, when searching their insurer’s provider directory, to find listings for physicians who are no longer practicing and no longer in-network, as well as inaccurate…
FDA issues warning letter to Philips regarding manufacturing facility
Philips received a warning letter from the FDA in February, which the Agency posted on Tuesday, stating that an inspection of the tech giant's manufacturing facility in Suzhou, China, that…
Most mentors in vitreoretinal subspecialty are men
Add topic to email alerts Receive an email when new articles are posted on Please provide your email address to receive an email when…
Amgen obesity drug MariTide: four key questions going forward
Amgen’s comments Thursday that it’s “very encouraged” by interim Phase 2 data for its obesity drug have quickly sparked immense investor interest in what could be a potential contender with…
New approach for developing cancer vaccines could make immunotherapies more effective in acute myeloid leukemia
UChicago Pritzker School of Molecular Engineering PhD candidate Anna Slezak is first author on recent paper on developing in-situ cancer vaccines could make immunotherapies more effective in the blood cancer…
Inflammatory disease not major risk factors for severe COVID-19, focus on comorbidities urged
In a recent study published in The Lancet Digital Health, a group of researchers analyzed severe coronavirus disease 2019 (COVID-19) outcomes in patients with immune-mediated inflammatory diseases (IMIDs), focusing on…